Sectors & IndustriesConsumer DefensiveBeverages - Wineries & Distilleries

Best Wine Stocks to Buy Now (2025)

Top wine stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best wine stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best alcohol stocks to buy right now are:

Sndl (NASDAQ:SNDL) is the #1 top wine stock out of 14 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Sndl (NASDAQ:SNDL) is: Value: D, Growth: C, Momentum: D, Sentiment: B, Safety: C, Financials: C, and AI: C.

Sndl (NASDAQ:SNDL) has a Due Diligence Score of 33, which is 6 points higher than the wine industry average of 27.

SNDL passed 10 out of 33 due diligence checks and has average fundamentals. Sndl has seen its stock lose -29.95% over the past year, overperforming other wine stocks by 7 percentage points.

Srx Health Solutions (NYSEMKT:SRXH) is the #2 top wine stock out of 14 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Srx Health Solutions (NYSEMKT:SRXH) is: Value: C, Growth: B, Momentum: F, Sentiment: C, Safety: C, Financials: C, and AI: F.

Srx Health Solutions (NYSEMKT:SRXH) has a Due Diligence Score of 37, which is 10 points higher than the wine industry average of 27.

SRXH passed 11 out of 33 due diligence checks and has average fundamentals. Srx Health Solutions has seen its stock lose -83.13% over the past year, underperforming other wine stocks by -46 percentage points.

Constellation Brands (NYSE:STZ) is the #3 top wine stock out of 14 with a Zen Rating of C. Stocks with a rating of C have had an average return of +7.53% per year. Learn more.

The Component Grade breakdown for Constellation Brands (NYSE:STZ) is: Value: C, Growth: C, Momentum: D, Sentiment: D, Safety: C, Financials: B, and AI: C.

Constellation Brands (NYSE:STZ) has a Due Diligence Score of 25, which is -2 points lower than the wine industry average of 27.

STZ passed 8 out of 38 due diligence checks and has weak fundamentals. Constellation Brands has seen its stock lose -32.81% over the past year, overperforming other wine stocks by 4 percentage points.

Constellation Brands has an average 1 year price target of $206.88, an upside of 21.3% from Constellation Brands's current stock price of $170.55.

Constellation Brands stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Constellation Brands, 37.5% have issued a Strong Buy rating, 25% have issued a Buy, 37.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 4 wine stocks that have issued dividends in the past year, the 3 wine stocks with the highest dividend yields are:

Diageo (NYSE:DEO) has an annual dividend yield of 3.93%, which is 2 percentage points higher than the wine industry average of 2.35%. Diageo's dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Diageo's dividend has not shown consistent growth over the last 10 years.

Diageo's dividend payout ratio of 46.5% indicates that its high dividend yield is sustainable for the long-term.

Constellation Brands (NYSE:STZ) has an annual dividend yield of 2.37%, which is the same as the wine industry average of 2.35%. Constellation Brands's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Constellation Brands's dividend has shown consistent growth over the last 10 years.

Constellation Brands's dividend payout ratio of -172.3% indicates that its dividend yield might not be sustainable for the long-term.

Brown Forman (NYSE:BF.B) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the wine industry average of 2.35%. Brown Forman's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Brown Forman's dividend has shown consistent growth over the last 10 years.

Brown Forman's dividend payout ratio of 36.6% indicates that its dividend yield is sustainable for the long-term.

Wine stocks were up 1.38% in the last day, and up 1.75% over the last week.

We couldn't find a catalyst for why wine stocks are up.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued wine stocks right now are:

Mgp Ingredients (NASDAQ:MGPI) is the most undervalued wine stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Mgp Ingredients has a valuation score of 43, which is 22 points higher than the wine industry average of 21. It passed 3 out of 7 valuation due diligence checks.

Mgp Ingredients's stock has dropped -54.51% in the past year. It has underperformed other stocks in the wine industry by -17 percentage points.

Diageo (NYSE:DEO) is the second most undervalued wine stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Diageo has a valuation score of 29, which is 8 points higher than the wine industry average of 21. It passed 2 out of 7 valuation due diligence checks.

Diageo's stock has dropped -17.88% in the past year. It has overperformed other stocks in the wine industry by 19 percentage points.

Srx Health Solutions (NYSEMKT:SRXH) is the third most undervalued wine stock based on its Valuation Rating of C. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Srx Health Solutions has a valuation score of 43, which is 22 points higher than the wine industry average of 21. It passed 3 out of 7 valuation due diligence checks.

Srx Health Solutions's stock has dropped -83.13% in the past year. It has underperformed other stocks in the wine industry by -46 percentage points.

33.33% of wine stocks rated by analysts are a strong buy right now. On average, analysts expect wine stocks to rise by 19.85% over the next year.

0% of wine stocks have a Zen Rating of A (Strong Buy), 0% of wine stocks are rated B (Buy), 80% are rated C (Hold), 20% are rated D (Sell), and 0% are rated F (Strong Sell).